Pituitary ablation was used to treat diabetic retinopathy in twelve patients. The treatment was associated with stabilization and lack of progression of visual findings in seven patients for thirty to ninety-nine months following surgery with loss of growth hormone responsiveness in three, lowering of fasting growth hormone levels in three and lowering of growth hormone reserve in one. Renal function (glomerular filtration rate and renal plasma flow) was reduced by 30 to 37 per cent within four months following surgery in those patients who showed loss of growth hormone activity. Reduced function was ameliorated with human growth hormone. Renal clearance studies indicate that loss of growth hormone may lead to increased renal arterial resistance. A beneficial effect on renal function was not observed in later observation periods. The decreased insulin requirement and increased morbidity in the posthypophysectomy state seem to be related to the loss of growth hormone. DIABETES J9: 502-18, July, 1970. Encouraging results observed over the years make it clear that pituitary ablation is a valuable procedure for stabilizing or improving progressive diabetic retinopathy. 1 -29 Transethmoido-sphenoidal hypophysectomy is associated with practically no mortality and little morbidity. Even though the endocrine patterns which result from this procedure vary considerably, diminution of growth hormone levels seems to be the most important factor associated with stabilization of progressive diabetic retinopathy. Nevertheless, follow-up of patients for up
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.